Characteristics such as MSI and a high mutation load in malignancies from patients with Lynch syndrome or spontaneous cancers harboring MLH1 promoter methylation indicate that epimutations, as well as somatic mutations affecting MLH1, are early events during malignant transformation [23]. The gene discussed is MLH1; the disease is cancer.